Global CBD Pet Market is valued approximately at USD 3.01 billion in 2023 and is anticipated to grow with an astonishing compound annual growth rate of more than 32.47% over the forecast period 2024–2032. As modern pet owners increasingly seek holistic and alternative wellness remedies for their companions, the CBD pet market has rapidly gained momentum, transforming from niche novelty to mainstream necessity. Cannabidiol (CBD), a non-psychoactive compound derived from hemp, is now being embraced as a therapeutic agent across a spectrum of pet health concerns—from joint mobility and chronic pain to behavioral disorders and neurological imbalances. With heightened emphasis on pet well-being, human-grade standards, and product transparency, the market is evolving into a regulated ecosystem teeming with innovation and functional product development.
The surge in pet adoption rates, coupled with heightened awareness about pet health, has intensified demand for natural supplements, especially among millennial and Gen Z pet parents. CBD-infused treats, oils, tinctures, and topicals are witnessing remarkable consumer traction due to their perceived safety profile and minimal side effects. Furthermore, increasing incidences of stress-induced conditions, such as separation anxiety and age-related arthritis in pets, are propelling owners to proactively adopt preventative care using CBD formulations. Industry players are strategically differentiating their offerings by formulating species-specific, condition-targeted products backed by research, while also integrating QR-coded transparency and third-party testing to build consumer trust.
Despite its explosive growth, the market faces regulatory ambiguities, especially surrounding labeling, dosage consistency, and inter-state commerce, which remain prominent barriers. Additionally, limited long-term clinical data, combined with varying degrees of veterinarian endorsement, continues to influence consumer hesitancy in certain demographics. Moreover, the high cost of premium CBD pet products may restrict adoption in price-sensitive regions. Nevertheless, as scientific consensus strengthens and federal frameworks evolve toward clearer guidelines, stakeholder confidence is expected to surge, reinforcing CBD’s standing as a reliable adjunct to conventional veterinary treatment.
Another dynamic shaping the market is the digitalization of pet care retail. E-commerce platforms and direct-to-consumer brands are leveraging data analytics, personalized recommendation engines, and social media marketing to foster loyal customer bases. Subscription-based services and curated CBD wellness boxes are also making inroads, creating recurring revenue streams while offering pet parents convenience and continuity. From hemp-sourced origin tracking to QR-enabled lab result access, product transparency is becoming a key brand differentiator that appeals to health-conscious consumers. This digitized approach is particularly crucial in urban markets, where convenience often dictates purchase behavior.
Regionally, North America dominated the CBD pet market in 2023, buoyed by an established CBD legal framework in the U.S. and growing pet humanization trends. Europe is not far behind, with nations like Germany, the UK, and the Netherlands gradually liberalizing CBD regulations and embracing natural pet wellness solutions. Meanwhile, the Asia Pacific region is emerging as a lucrative frontier, especially in countries like Japan, South Korea, and Australia, where alternative therapies for pets are gaining cultural acceptance. Latin America and the Middle East & Africa, though nascent in regulatory maturity, are anticipated to open up as CBD awareness, veterinary education, and retail infrastructure expand.
Major market player included in this report are:
• HolistaPet
• Pet Releaf
• CBD Living
• Honest Paws
• Charlotte’s Web Holdings Inc.
• Medterra
• Joy Organics
• Canna-Pet
• King Kanine
• Innovet Pet Products
• Green Roads
• HempMy Pet
• Fomo Bones
• PureKana
• Paw CBD
The detailed segments and sub-segment of the market are explained below:
By Animal Type
• Dogs
• Cats
By Indication
• Joint Pain
• Anxiety/Stress
• Epilepsy
By Distribution Channel
• Pet Specialty Stores
• E-commerce
• CBD Store
By Region:
North America
• U.S.
• Canada
Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa
Years considered for the study are as follows:
• Historical Year – 2022
• Base Year – 2023
• Forecast Period – 2024 to 2032
Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook